These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Letter: switching from one to another anti-tumour necrosis factor alpha agent, and the risks of an overlap of exposure--authors' reply. Gisbert JP; Chaparro M Aliment Pharmacol Ther; 2016 May; 43(9):1020. PubMed ID: 27040169 [No Abstract] [Full Text] [Related]
10. Editorial: methotrexate vs azathioprine-do differential rates of discontinuation settle the debate? Authors' reply. Vasudevan A; Con D; Nicolaides S; van Langenberg DR Aliment Pharmacol Ther; 2020 Nov; 52(9):1529-1530. PubMed ID: 33263380 [No Abstract] [Full Text] [Related]
11. Reply to Soteriadou et al. Dave M; Purohit T; Razonable RR; Loftus EV Inflamm Bowel Dis; 2014 Feb; 20(2):E5-6. PubMed ID: 24374883 [No Abstract] [Full Text] [Related]
15. The "Q" of fever in inflammatory bowel disease. Soteriadou S; Blanchard T; Limdi JK Inflamm Bowel Dis; 2014 Feb; 20(2):E4-5. PubMed ID: 24374882 [No Abstract] [Full Text] [Related]
16. Risk of melanoma in patients who receive thiopurines for inflammatory bowel disease is not increased. Peyrin-Biroulet L; Chevaux JB; Bouvier AM; Carrat F; Beaugerie L Am J Gastroenterol; 2012 Sep; 107(9):1443-4. PubMed ID: 22951883 [No Abstract] [Full Text] [Related]
17. Azathioprine side effects in the treatment of chronic inflammatory bowel disease. González Lara V; Pérez Calle JL Rev Esp Enferm Dig; 2001 Dec; 93(12):765-8. PubMed ID: 11995358 [No Abstract] [Full Text] [Related]
18. [Is the risk of lymphoma increased by immunosuppressive therapy in patients with inflammatory bowel disease? The missing link for considering early immunosuppressants]. Beaugerie L Gastroenterol Clin Biol; 2004 Mar; 28(3):218-20. PubMed ID: 15094669 [No Abstract] [Full Text] [Related]
19. Vedolizumab is an effective alternative in inflammatory bowel disease patients with anti-TNF-alpha therapy-induced dermatological side effects. Pijls PA; Gilissen LP Dig Liver Dis; 2016 Nov; 48(11):1391-1393. PubMed ID: 27639825 [TBL] [Abstract][Full Text] [Related]
20. Risk of lymphoma: inflammatory bowel disease and immunomodulators. Ang YS; Farrell RJ Gut; 2006 Apr; 55(4):580-1. PubMed ID: 16531538 [No Abstract] [Full Text] [Related] [Next] [New Search]